Clinical Trials Insight: 700024263
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 04 Feb 2008
At a glance
- Drugs Nalbuphine (Primary)
- Indications Musculoskeletal pain; Osteoarthritis; Pain
- Focus Therapeutic Use
- Sponsors Penwest Pharmaceuticals
- 04 Feb 2008 Primary endpoint 'Sum of pain intensity difference' has not been met.
- 04 Feb 2008 Primary endpoint not met; results reported in a Penwest media release.
- 26 Oct 2007 Patient enrollment has been completed and preliminary results are expected in the first quarter of 2008.